Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213809-20-000009
Filing Date
2020-01-03
Accepted
2020-01-03 20:56:17
Documents
1
Period of Report
2020-01-02

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_157810295938452.html 4  
1 FORM 4 wf-form4_157810295938452.xml 4 3814
  Complete submission text file 0001213809-20-000009.txt   5334
Mailing Address 140 INTRACOASTAL POINTE DRIVE SUITE 404 JUPITER FL 33477
Business Address 140 INTRACOASTAL POINTE DRIVE SUITE 404 JUPITER FL 33477 561-743-8333
DYADIC INTERNATIONAL INC (Issuer) CIK: 0001213809 (see all company filings)

EIN.: 450486747 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 140 INTRACOASTAL POINTE DRIVE SUITE 404 JUPITER X1 33477
Business Address
Jones Matthew S. (Reporting) CIK: 0001762747 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-32513 | Film No.: 20507881